# Astera Labs Inc. (ALAB) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Technology / Semiconductors & Semiconductor Equipment. Price $310.40, market value $53.8 billion.

## Valuation
- **P/E (trailing): 153.7×** (5-yr avg 136.4×, 3-yr avg 136.4×). Astera Labs Inc. trades at 153.7× trailing earnings, close to its own five-year average of 136.4×. The Technology median in the September 2026 study was 32.1×. Forward P/E is 48.5×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.17**. A PEG of 0.17 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 44.8×**. Each dollar of revenue is priced at 44.8×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 31.2×**. The shares trade at 31.2× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 0.5%** (5-yr avg 0.8%). Free cash flow equals 0.5% of the market value, below its five-year average of 0.8%, so the shares are pricier on cash than usual.
- **Earnings yield: 0.7%**. The inverse of the P/E: 0.7% of the price is earned each year.

## Profitability
- **Gross margin: 75.1%**. Astera Labs Inc. keeps 75.1% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 22.8%**. 22.8% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 25.7%**. 25.7% of each dollar of sales reaches the bottom line.
- **Return on equity: 16.1%**. 16.1% on shareholders' equity is solid.
- **Return on assets: 24.1%**. Each dollar of assets produces 24.1% of profit.

## Growth
- **Revenue growth (1 yr): 115.1%** (3-yr 120.2%/yr). Revenue grew 115.1% over the last year.
- **EPS growth (1 yr): 290.6%**. Earnings per share rose 290.6%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 10.24** (quick 10.24). Current assets cover the next year's liabilities 10.24 times.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Astera Labs Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (23 analysts). 23 analysts cover Astera Labs Inc.; the consensus is buy, with an average price target of $389.95 (+26% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 65.2%** (YTD 86.6%, 3-mo -2.1%). The shares are up 65.2% over twelve months including dividends.
- **From 52-week high: -37.9%** (217.1% above the low). Trading 38% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 52**. An RSI of 52 is neutral.
- **Beta (1 yr): 3.70** (volatility 98%). Beta of 3.70 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ALAB · Page: https://foliofundamentals.com/stocks/alab

Not investment advice.